News

Outsourcing facilities were created under the federal Drug Quality and Security Act (DQSA) enacted in November 2013. Under the agreement, Cantrell Drug Company will prepare sterile compounded medications

Cipralex had annual sales of approximately $260 million in Canada , based on IMS Brogan sales data as of July 10, 2014. PrTeva-Escitalopram is available immediately in pharmacies

As part of the deal, Genmab will pay an upfront fee of $11m for exclusive rights to use Seattle’s auristatin-based ADC technology with its HuMax-AXL, an antibody targeting

VC-01 has recently secured clearance from the US Food and Drug Administration (FDA) to initiate evaluation in human clinical trials. The company’s stem cell-based therapy has been supported

Arixtra is indicated to treat prophylaxis of deep vein thrombosis (DVT), which may lead to pulmonary embolism (PE) in patients undergoing hip fracture surgery, including extended prophylaxis, hip

The funding was pledged today by the UK Foreign Office Minister responsible for Africa, James Duddridge, and South Africa’s Minister for Science and Technology, Naledi Pandor, at an

The insulin glargine product is the first insulin treatment approved through the European Medicines Agency’s (EMA’s) biosimilar pathway and the fourth diabetes product approved in the European Union

Patheon, the pharmaceutical services business unit of DPx Holdings B.V., is a global provider of development and commercial manufacturing services for prescription drugs. "With this Patheon agreement completed

Under the terms of the agreement, Sutro will provide its Xpress CF technology for the rapid and reproducible expression of antibodies and antigens by the Wells Lab for